HUTCHMED (China) (HCM) Consolidated Net Income (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Consolidated Net Income of -$61.0 million for Q1 2021, down 101.38% year-over-year from $4.4 billion in Q1 2020, and down 37.71% quarter-over-quarter from -$44.3 million in Q2 2020.
HUTCHMED (China) (HCM) Consolidated Net Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Consolidated Net Income for 6 consecutive years, with -$61.0 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Consolidated Net Income fell 101.38% year-over-year to -$61.0 million; the TTM figure through Jun 2022 stood at -$61.0 million (up 42.07% YoY), while the FY2025 annual figure was $64.4 million, up 1104.94% from the prior year.
- Consolidated Net Income eased to -$61.0 million in Q1 2021 per HCM's latest filing, from -$44.3 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $70.1 million in Q2 2018 and bottomed at -$99.4 million in Q2 2019.
- Historically, Consolidated Net Income has averaged -$17.3 million across 4 years, with a median of -$30.3 million in 2020.
- On a YoY basis, Consolidated Net Income climbed as much as 250.63% in 2019 and fell as far as 367.87% in 2019.
- HUTCHMED (China)'s Consolidated Net Income stood at $22.1 million in 2018, then plunged by 270.87% to -$37.8 million in 2019, then declined by 17.28% to -$44.3 million in 2020, then tumbled by 37.71% to -$61.0 million in 2021.
- Business Quant data shows HCM's Consolidated Net Income at -$61.0 million in Q1 2021, -$44.3 million in Q2 2020, and -$30.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -60.97 Mn |
| Jun 30, 2020 | -44.27 Mn |
| Mar 31, 2020 | -30.28 Mn |
| Dec 31, 2019 | -37.75 Mn |
| Sep 30, 2019 | -34.24 Mn |
| Jun 30, 2019 | -99.44 Mn |
| Mar 31, 2019 | 33.60 Mn |
| Dec 31, 2018 | 22.09 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 70.12 Mn |
| Mar 31, 2018 | -22.31 Mn |
| Jun 30, 2016 | 29.56 Mn |
| Jun 30, 2015 | 23.49 Mn |